Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Current regulatory requirements for APIs

The adoption of a global regulatory framework for active pharmaceutical ingredients (APIs) can only be of benefit to the licensing authorities, the industry and - last but not least - the patient.

Dr Chris Oldenhof, DSM/Gist-brocades (January 2000)

Keywords: peptides, fine chemicals, active pharmaceutical ingredients, contract manufacturing, chiral, chiral synthesis, , chiral technology, intermediates, enantiomers, bulk pharmaceuticals, chemical synthesis, galenic development, raw materials, biocatalysts, botanicals, biochemistry, chemical analysis, solid phase combinatorial synthesis, specialty chemicals, intermediate synthesis, peptide chemistry, DSM/Gist-brocades, active pharmaceutical ingredients, APIs

    View full article    |    Back to Manufacturing section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |